The Morris Lab’s paper, “Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Anti-parasitic Activity” has been accepted for publication in Antimicrobial Agents and Chemotherapy.
The effort involves folks at NIH National Center for Advancing Translational Sciences, UVA, the University of Wisconsin-Madison, the Ohio State University, and of course Clemson! This work was supported in part by the US National Institutes of Health 1R03HD081723 to Jim Morris and in part by the Intramural Research Program of the NIH, NCATS and the Fiske Drug Discovery Lab at the University of Virginia.
EPIC’s own Jessica Jones, a PhD student in the Department of Genetics and Biochemistry in the Jim Morris Lab was […]
Phillip Burkhardt, and undergraduate Biochemistry major in the J Morris lab, was selected to attend the 2nd Annual St. Jude Graduate School of Biomedical […]
Senior biochemistry major Diana Nguyen was selected as a Scholar by the National Institutes of Health Undergraduate Scholarship Program (NIH-UGSP). […]